Exploring patient delay in people with chronic kidney disease: A cross-sectional study

Jie Zheng,Ao-Han Guo,Bo-Wen Xue,Shu-Yan Wu,Xi-Xiang Wang,Yue-Juan Jing,Lin-Jun Zhai,Rong Liu

DOI: https://doi.org/10.1097/md.0000000000037077

IF: 1.6

2024-02-17

Medicine

Abstract:Chronic kidney disease (CKD) is defined as abnormalities of kidney structure or function, which is present for more than 3 months and have implications for health. [ 1 ] Diagnosis of the disease requires 1 of 2 criteria documented or inferred for > 3 months: either GFR < 60 mL/min/1.73 m 2 or markers of kidney damage, including albuminuria. [ 2 ] CKD affects 8% to 16% of the population worldwide, [ 3 ] and as a result, up to 2.4 million people die each year. [ 4 , 5 ] The prevalence of CKD in adults in China is up to 10.8%, and 20% to 30% of patients have irreversible kidney damage at the time of their first visit. [ 6 ] The failure of patients with CKD in seeking early intervention can lead to a dramatic rise in treatment expenses, a high mortality and disability rate, anxiety or depression, and place an immense burden on their families, society, and healthcare. [ 7–9 ] CKD has grown to be one of the most significant public health issues affecting human health. [ 10 ]

medicine, general & internal